27.11.2012 Views

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

DSM Fine Chemicals<br />

P.O. Box 43<br />

Sittard 6130 AA, Netherlands<br />

Phone: +31 (46) 4773487; Fax: +31 (46) 4773172<br />

Web: www.dsm.com<br />

E-mail: info@dsm.com<br />

KEY PERSONNEL: Jan Wolters; Business Group Director, DSM Fine Chemicals<br />

Andrea Pollak; Business Unit Director, DSM ACTIS<br />

Frank Teeuwisse; Business Unit, Director DSM Minera<br />

Jan Vriens; Business Unit Director, Special Products<br />

EMPLOYEES: 2,700 employees<br />

HISTORY: Acquired BMS Regensburg (fine chemicals activities)<br />

Acquired 70% of Chemie Linz (Austria) (1/96)<br />

Acquired Deretil (9/96)<br />

FACILITIES: Plant in Holland to produce aspartame<br />

Multipurpose plants for fine chemical intermediates produced by enzyme<br />

technology<br />

Biotech R&D facility<br />

STOCK-FINANCIAL HISTORY: Privately held<br />

SUBSIDIARIES/DIVISIONS: Three business units:<br />

DSM ACTIS<br />

DSM Minera<br />

DSM Special Products<br />

SUBSIDIARY OF: DSM (see separate entry)<br />

INVESTMENTS: Holland Sweetener Co.--joint venture with TOSOH Corp. for aspartame<br />

Chemferm--joint venture with Gist-brocades for semi-synthetic<br />

cephalosporines<br />

Bio-Intermediair International Holding BV--7%<br />

BUSINESS STRATEGY: Mission:<br />

To become the partner of choice for innovative life science companies<br />

based upon:<br />

-A superior technology toolbox<br />

-Optimal production facilities<br />

-Service throughout the product life cycle<br />

To ensure our customers benefit from our global leadership and extensive<br />

expertise in:<br />

-The manufacturing of standard and advanced intermediates<br />

-The manufacturing of active ingredients<br />

-Upscaling from kg- to ton-scale<br />

-New process development<br />

-Exclusive synthesis and custom development<br />

RESEARCH & DEVELOPMENT: Aspartame<br />

L- and D-amino acids via enzymatic resolutions, as well as other optically<br />

active compounds<br />

PRODUCTS ON MARKET: REGULAR PRODUCTS: Acetaldehyde oxime, Acetonyl succinic acid<br />

diethylester, 2-Acetylnicotinic Acid, Allantoin, 2-Amino-4,6dimethoxypyrimidine,<br />

D,L-Aspartic acid, L-Aspartic acid, Benzaldehyde,<br />

Benzoic acid, Benzylalcohol, N-Bromosuccinimide, N-tert.-Butylacrylamide,<br />

N-Butyl levulinate, Carbethoxypyrazolone, N-Chlorosuccinimide, Cinnamic<br />

alcohol, Cinnamic aldehyde, Copper iodide, 1,3-Cyclohexanedione, 1,4-<br />

Cyclohexanedione, Cyclohexanone oxime, Diacetone acrylamide, 1,4-<br />

Diaminobutane, N,N’-Dibenzylethylenediamine diacetate, N,N-<br />

Dibenzylamine, 1,3 Dibromo-5,5-dimethylhydantion, 2,2<br />

Dichlorophenylacetic acid ethylester, Diethyl maleate, Diethyl succinate,<br />

Copyright ©2006 AHC Media ® 143

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!